Page Banner

United States Department of Agriculture

Agricultural Research Service

Title: Swine Immune Response to Toxoplasma Gondii Infections and to Vaccination with Irradiated Oocysts

Authors
item Lunney, Joan
item Solano-Aguilar, Gloria
item Hyatt, Sarah
item Dubey, Jitender

Submitted to: Research Workers in Animal Diseases Conference Proceedings
Publication Type: Abstract Only
Publication Acceptance Date: October 22, 1998
Publication Date: N/A

Technical Abstract: Swine infected with low doses (200-1000 oocysts) of VEG strain of T. gondii have been analyzed for their immune responses to infection. Analyses of cell subsets have shown an early (day 6-8) increase in peripheral blood CD4+/CD8+ T cells that returns to normal levels by day 14 of infection. Levels of activated monocytic cells are also increased in the first week after infection. Analyses of cytokine mRNA expression in peripheral blood lymphocytes from infected pigs show increases in interferon-g (IFN-g) levels as compared to cells from uninfected pigs. Recent studies have been aimed at documenting a T. gondii vaccination model using irradiated oocysts. Preliminary studies showed that pigs vaccinated with 10,000 VEG strain oocysts, irradiated with 0.3 kGy Cs137, were protected against challenge high (10x6) or low (10x3) dose T. gondii oocyst inocula, as determined by clinical signs and by recovery of viable parasite from tissues. Antibody levels were measured during the vaccination process and were found not to be predictive of the protection stimulated by the vaccination. Repeat vaccination studies showed that irradiated oocysts clearly protect pigs from clinical disease but do not fully prevent cyst development. Therefore, irradiated oocysts are not fully protective against T. gondii infection. Data from these studies should help to determine whether specific cell subsets or cytokines are preferentially stimulated during vaccination responses and whether in vitro assays, such as measurement of cytokine levels, are potential predictors of positive T. gondii vaccination responses.

Last Modified: 8/29/2014
Footer Content Back to Top of Page